Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · operational-macro

IRhythm grows heart monitoring leadership with $288M VitalConnect buy

10 August 2026 · By · Wire by Fusion42

Published

10 August 2026

Topic

operational-macro

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at medtechdive.com →

◆ Verified

Fusion42 · 24 August 2026 · Fusion42 review

iRhythm has acquired VitalConnect for $288M to strengthen its position in the heart monitoring market, potentially unlocking access to a $1 billion cardiac monitoring market not fully covered by its current products.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

You face growing competition and opportunity in cardiac monitoring as iRhythm’s acquisition opens up a sizeable market gap. This deal signals consolidation that might force you to upgrade or broaden your device offerings to stay relevant.

◆ Coverage

1 source · 10 Aug 2026

◆ Related on Wire

◆ Topics

Medtechmedtechmacardiac-monitoringheart-health